Olema Oncology Announces Upcoming Clinical Data Poster Presentation at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

October 12, 2022

https://www.globenewswire.com/news-release/2022/10/12/2532718/0/en/Olema-Oncology-Announces-Upcoming-Clinical-Data-Poster-Presentation-at-the-34th-EORTC-NCI-AACR-Symposium-on-Molecular-Targets-and-Cancer-Therapeutics.html

SAN FRANCISCO, Oct. 12, 2022 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq:OLMA) today announced that the Company will present updated clinical results from the OP-1250-001 study at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2022), taking place October 26-28, 2022, in Barcelona, Spain.

Read more at globenewswire.com

Related news for (OLMA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.